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ABSTRACT
Postoperative pam

IS

common following knee arthroscopy and

has been typically controlled with opioids, the most popular of which
is morphine.

Morphine has been traditionally administered by

intramuscular, intravenous, or epidural injections.

These methods of

administering morphine have been very effective in producing
prolonged analgesia; however, they have also produce negative
central nervous system side effects.
Recent research has suggested administering morphine via
intraarticular injections to provide postoperative analgesia without
the central nervous system side effects.

However, there is little

evidence to suggest that this method is effective.

Therefore, the

purposes of this randomized, double-blinded study were to 1)
investigate the effects of intraarticular injections of morphine on
pain, 2) determine the minimal effective dose of morphine, and
3) determine the effect of morphine on the need for supplemental
analgesia (pain pills).
Seventy-six subjects participated m the study and were
randomly injected with 0.0 mg, .25 mg, .50 mg, .75 mg, or 1.00 mg of

viii

morphine.

Pain was assessed at 1, 3, 6, and 24 hours postoperatively

using a 100 mm visual analogue scale.

Subject's requests for

supplemental analgesia were also recorded.
The results of this study found that any time interval > 5 hours
resulted in a significant decrease in pain.

The results of this study,

however, did not find intraarticular injections of morphine to
significantly reduce pain, or the need for supplemental analgesia.

ix

CHAPTER 1
INTRODUCTION
Knee arthroscopy is currently the most common orthopaedic
surgical procedure in the United States; 1.2 million are performed
each yearl.

Forty-one percent of these patients report significant

pain2, especially during the first twenty-four hours 3 .

Therefore,

postoperative pain is an important issue for physical therapists.
Pain affects patient comfort, discharge status, and overall
rehabilitation potential.

Studies have shown that severe pam

difficult to treat 3 and is frequently undermedicated 3 - 5 .

IS

Considering

the volume of arthroscopic procedures and the frequency of pain,
effective analgesics must be found.
Postoperative pain has been typically controlled with opioids,
the most popular of which is morphine.

Numerous studies have

shown morphine to be very effective for pain, producing prolonged
analgesia for 12 to 24 hours 3 ,5-9 .

Morphine accomplishes

this by blocking transmission of pain impulses, inhibiting afferent
pain pathways while sparing efferent motor and proprioceptive
functions 7 .

1

2

Opioid (or morphine) receptors are present at two sites 7 :
1)

The presynaptic endings of afferent pain fibers, or

2)

The interneuronal level within the dorsal horn of the spinal
cord.

Currently, the most popular method of administering morphine is
epidurally3,9.

This method directly affects the opioid receptors at the

interneuronal level in the spinal cord.

This effectively inhibits pain

throughout the central nervous system.
Along with it's advantages, morphine has several drawbacks
and some of them are severe (Table 1).

Epidural and intravenous

injections of morphine affect the central nervous system (CNS) and
produce negative side effects 5.

Research has documented that

morphine can produce nausea 6 ,9-13, vomiting 6 ,9-13, sedation 6 ,8,10-13,
delay in gastric emptying I1 - 13 , anaphlaxis12, pruritis 6 ,8-12, 14, urinary
retention 6 ,8-12,14, and even seizures 12 ,13.

One study found that

pruritis was prevalent in 5-10%, and urinary retention in 20-40% of
all cases l4 . The most severe side effect of morphine however, is
delayed respiratory depression which can occur up to twenty-four
hours later 6 , 8-15.

Delayed respiratory depression has been

documented in 4-7% of all cases l4 , and is especially dangerous to
patients with short hospital stays.

3

TABLE 1
Central Nervous

System

Side

Side Effect

Effects

of Morphine

Prevalence

Respiratory Depression

4%-7%a

Pruritis

5%-lO%a

Urinary Retention

20%-40%a

8.5%b

46%c

Nausea
Vomiting
Sedation
Delay in Gastric Emptying
Anaphlaxis
Seizures
a
b
C

Study by Gustafsson et aI14
Study by Sabbe et al ll
Prevalence when administered intrathecally.

all 1

Study by Sabbe et

4
Recent research has explored alternative ways to administer

morphine without these undesirable eNS effects 16.

Opioid receptors

outside of the eNS (or outside of the interneuronal level within the
spinal cord) were sought out.

Researchers have investigated opioid

receptors that would provide localized pain relief without the side
effects caused by affecting the central nervous system.
Interest began with a study by Stein et al 17 which implied that
"peripheral sites" of tissue could contain opioid receptors for
morphine.

Stein found peripheral opioid receptors in the hind paws

of rats, and morphine injected into inflamed areas produced
analgesia.
Further research by Stein and associates 18 found similar results
III

humans.

Stein found evidence of opioid receptors in the knee

joint, and demonstrated effective postoperative analgesia with
intraarticular injections of morphine.

Stein also found that

intraarticular injections of morphine gave significantly greater pam
relief than intravenous injections, and decreased the need for
supplemental analgesia (pain pills) 18.
hours after injection 18.

The maximal effect was 3-6

Furthermore, intraarticular injections of

morphine were found to be safe, with none of the negative eNS side
effects seen with epidural or intravenous morphine.

Stein cited two

5
reasons for the lack of CNS side effects.

First, pam was being blocked

in the knee joint (i.e. at the presynaptic level) as opposed to the ·
spinal cord level.

Second, the low lipid solubility of morphine

provided slow uptake out of the knee joint 18 ,19.

Both of these factors

reduced the CNS concentration of morphine providing pain relief
without the side effects.

Additional research done by Khoury et apo,

and Joshi et aPO,21 supported Stein and found intraarticular
morphine to significantly reduce pain without any side effects.
Contrasting studies performed by Raja et aP3, Ruwe et aI24, and
Heard et aP5 contradicted these results, finding no improvement in
pain relief with intraarticular morphine.

A study by Raja et aI23,

found morphine to have no significant analgesic effect during the
first two hours after surgery, similar to the observations reported by
Stein 18 .

However, Raja failed to demonstrate any delayed analgesic

effect of morphine.

Ruwe et aP4, also reported that morphine was

not beneficial for postoperative pain, even in combination with other
opioids.

Finally, Heard et aI25 failed to find a significant benefit of

morphine, even in larger volumes than used by Stein 18.
Other research has indicated another opioid, bupivacaine,
which may have a positive impact on pain when injected in the knee
joint.

Bupivacaine is an opioid that has been used to provide local,

6

surgical anesthesia lasting up to eight hours26.

Numerous studies

have found it to be safe, staying below toxic levels even with 100 mg
injections 23 ,25-29.
cartilage 30 .

Bupivacaine also does not damage articular

Recently, studies 20 ,23,25,31,32 have found bupivacaine to

be effective in providing post-operative pain relief when injected
into the knee joint.

Khoury et apo found that bupivacaine produced

immediate, short-term pain relief.

Raja et aP3 also found it to be

effective for a short period of time (two hours).

Research by Heard

et aP5, Chirwa et aP 1, and Smith et aP2 all reported both short-term
and prolonged pain relief through bupivacaine.

However, other

studies 2,22,24,26 conflicted with these findings, and failed to show any
beneficial effect.

Research by Khoury et apo, and Joshi et aP2

reported conflicting results on the effectiveness of bupivacaine; but
both studies compared bupivacaine to morphine and found morphine
to be more effective in relieving postoperative pam.

Additional

research on bupivacaine is needed, but for the purposes of this
study; only the effect of morphine on pain relief was investigated.
Postoperative pain relief is an important issue, and the results
of past studies are varied.

Further research is needed to determine

if intraarticular morphine is or is not an effective method of
controlling postoperative pain.

The purpose of this randomized,

7

double-blinded study was to compare morphine to a placebo injected
into the knee after arthroscopic surgery.

This study sought to

determine if intraarticular morphine was an effective treatment for
postoperative pain and if so, determine the minimal effective dose.
The effect of intraarticular morphine on the need for supplemental
analgesia (pain pills) was also recorded.

CHAPTER 2
:METHODS

Patients
The study protocol was approved by the United Hospital
(Grand Forks, ND) institutional research committee, prior to
beginning the study (See Appendix A).

Seventy-six subjects (fifty

males and twenty-six females) between the ages of 15-55
participated in this study.

Each patient underwent elective

outpatient arthroscopic knee surgery performed by a single surgeon
(Dr. Brian T. Briggs) at Grand Forks United Hospital.

The surgical

procedures included partial menisectomies, plicectomies, and ·
grade(s) 1,2,3 chondromalacia.

Patients were excluded from the

study for the following reasons: an allergy or sensitivity to morphine,
not completing all the necessary questionnaires, or undergoing
procedures for grade 4 chondromalacia, lateral retinacular release, or
osteochondritis dessicans.
Study Design
Preoperatively, all patients were educated with regard to
postoperative pain measurements and the use of the Visual Analogue
8

Scale (V AS).

9
General anesthesia was used in all cases, and no

narcotics were administered intraoperatively.

A tourniquet was

applied ten minutes before the incision was made, and removed after
the procedure, an average of 25-30 minutes later.

At the conclusion

of the surgery, a double-blinded procedure was used to randomly
inject the patient with one of five solutions.

A placebo or a solution

containing morphine was injected directly into the knee joint.
1 (N=15) received an injection of 10 cc's normal saline.

Group

Group 2

(N=15) received 10 cc's of normal saline and 0.25 mg morphine.
Group 3 (N=14) received 10 cc's of normal saline and 0.50 mg
morphine.

Group 4 (N=19) received 10 cc's of normal saline and 0.75

mg morphine.

Group 5 (N=13) received 10 cc's of normal saline and

1.00 mg morphine.

The injections were prepared by a pharmacist,

randomized, and were revealed only at the completion of the study.
The operating physician, the nursing staff, nor the patient were
aware of the dosage.
Pain assessment
Postoperative pam was assessed with a 100-mm Visual
Analogue Scale (VAS).
36 ,

Studies have shown the VAS to be simple 33 -

reliable 33 ,37 , valid 33 - 39 , and the most sensitive 33 ,36-38 measure of

pam.

The scale ranged from no pain (0 mm), to excruciating or

unbearable pain (100 mm) (Fig. 1).

Subjects were asked to place

10

a vertical line on the scale to mark the pain they were feeling at that
moment.

V AS scores were recorded at 1, 3, 6, and 24 hours post-

operatively.

In addition, supplemental analgesia of Darvocet #100

and Tylenol #3 were made available to the patients and their use
was documented.
Statistical analysis
The V AS score was obtained by measuring the distance in
millimeters from zero (no pain) to the mark made by the patient.
These measurements were taken by the same person to ensure
consistent, reliable results.

Comparisons of pain scores from the V AS

and the need for supplemental analgesia were made using the Abstat
Version 1.8 computer software (Anderson-Bell Corporation, Arvada,
Co

80006).

A two-way analysis of variance with repeated measures

was used to analyze the relationship between morphine and pain.
one-way analysis of variance was used to compare the need for
supplemental analgesia and pain.
A p value of

<

.05 was considered to be statistically significant.

A

~
~

NO PAIN I

Figure 1.

IEXCRUCIATING 0
UNBEARABLE PAIN

100 mm visual analogue scale.

CHAPTER 3

RESULTS
One hundred patients received intraarticular injections, and
seventy-six were included in this study.

The other twenty-four

patients were excluded due to incomplete questionnaires.

There

were no significant differences among the groups in regards to
gender or type of surgical procedure.
There was a significant decrease m pain (i.e. lower VAS scores)
within all groups over the twenty-four hour time period (Table 2)
(Figure 2).

Scheffe and Tukey post hoc tests found that any time

interval > 5 hours resulted in significant decreases in pain.

This held

true for all groups regardless of morphine dose or number of pain
pills taken.

There were no significant differences between any of the

five groups at any of the time intervals (1, 3, 6, or 24 hours postoperatively) (Table 2).
The most significant finding of this study was that
intraarticular morphine injections did not significantly decrease V AS
pam scores.

A two-way ANOVA with replications indicated that

there were no significant differences in pain between the control
group (group 1), and any of the treatment groups (groups 2-5)
12

13

TABLE 2
Two Factor (Morphine Dose x Time) Analysis of Variance
with Repeated Measures for One Factor (Time)
Source

d

SS

Between Subjects
Morphine Dose
Error

4
71

44.756
808.660

11.1891
11.3896

Within Subjects
Time a
3
Morphine Dose x Time 12
Error
213

141.419
13.900
526.324

47.1398
1.1583
2.4710

303

1533.020

TOTAL

MS

a Time of recording VAS score (VAS at 1, 3, 6, 24 hours)
b Significant at p < .05

F

p

.982

.4228

19.0772b .0000
.4688 .9313

14
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Figure 2. Visual analogue scale score (in mm's) over time for eact1 treatment
group; significant at p <.00001.
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which had received morphine (Table 2).

This table illustrates the

variability of VAS results between each group.
visual analogue scores for each treatment group.

Figure 3 shows the
Interestingly, while

not significant, the control group (0.0 mg morphine) demonstrated
the lowest VAS at 1,3,6, and 24 hours.
The presence or absence of morphine also did not have a
significant impact on patient's requests for analgesics.

Descriptive

statistics on the amount of supplemental analgesics taken and the
V AS for each treatment group are shown on Table 3.

The number of

pain pills taken was consistent across all five treatment groups
(Figure 4).

5.
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Figure 3. Visual analogue scale score (in mm's) for each treatment group at 1,3,6, and 24
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TABLE 3
Results of Visual Analogue Scores (VAS) and Need for
Supplemental Analgesia (Pain Pills) Among Different
Treatment Groups
Amount

of Morphine (mg)

Group

o

.25

.5

.75

1.00

VAS (mm's)
Mean
Range

2.302
0.0 -7.4

3.010
0.1- 8.5

3.147
0.1- 9.3

2.955
0.0- 8.6

2.314
0.0- 8.3

# Pain Pills
Mean
Range

2.533
0.0- 5.0

3.333
0.0- 8.0

3.357
0.0- 8.0

3.316
0.0- 8.0

1.538
0.0- 6.0

4

p

a 3

n
P

2
I--'

00

1 -

s
00.0 MG

.25 MG

.5 MG

.75 MG

1.0 MG

Figure 4. Average amount of supplemental analgesics taken by each treatment
group.

CHAPTER 4
DISCUSSION
The results of this study found that intraarticular injections of
morphine had no significant effect on postoperative pain or need for
supplemental analgesia.

These results support similar findings by

Raja et aI23, Ruwe et aI24, and Heard et aps.
The results were m disagreement with those reported by Stein
et aIl8, Khoury et apo, and Joshi et aP2. Stein et aIl8 reported a
significant reduction in pain with morphine; however, this effect was
only at a single point in time (3 hours after injection).

Additionally,

Stein and associates 18 did not report on patients in the control group
of their study.

The study performed by Khoury et apo did not

include a control or placebo group, and the results may have also
been biased by the subject size (N=7).

Results reported by Joshi et

aI22 were also compiled from a limited number of subjects (N=20).
There are other possible explanations for discrepancies with
these studies.

Joshi et aP2 used a significantly higher dose of

morphine (5 mg) when compared to the highest dose used in this
study (1 mg).

It is possible that higher doses of morphine will elicit
19

the desired analgesic effects.

20
Also, in the study by Stein et all 8 ,

patients received a larger volume of intraarticular injection (40 ml).
This could have contributed significantly to the absorption of
morphine and relief of pain.
This study may also have included other factors which affected
the outcome.
study.

Pre-surgical pain scores were not obtained in this

This is important as pain is a combination of both

physiological and psychological factors 37 . In fact, in studies by Ruwe
et aP4 and Henderson et aP6, pre-surgical pam scores were found to
be the most significant indicator of post-surgical pain.
Another factor which may have affected the outcome was the
variable length of tourniquet inflation.

Studies by Joshi et al 40 and

Katz et al 41 have reported that the tourniquet should be inflated a
minimum of ten minutes after injection.

This facilitates local tissue

binding in the knee joint and increases the effect of morphine.

In

this study, the tourniquet was in place an average of 25-30 minutes
total.

However, the amount of time it was in place after injection was

variable, which may have influenced the results.
This study also used general anesthesia as opposed to regional
anesthesia.

This could have been an additional factor as research by

Heard and associates 25 found significantly lower (p

< .05) VAS scores

21
III

patients who underwent regional anesthesia, regardless of post-

operative pain treatments.
Finally, the method of pain interpretation or VAS also had it's
limitations.

Numerous authors 34 ,36-39,42 have stated that the VAS

has two deficiencies; a source of error introduced with measurement
of the patient's slash mark, and the effect of age on validity.
Research by Kremer et al 42 found a significant correlation between
the patient's age and incorrect responses.

Another author 38 stated

that the VAS "not be employed as a primary measure of pain
intensity in adult clinical populations".

These findings and opinions

certainly applied to this study as the patient population age was 1555.

However, I believe the benefits, reliability, and validity of the

VAS far outweigh these proposed drawbacks.

CHAPTERS
CONCLUSION

The results of this study suggest that morphine injections into
the knee joint after arthroscopic surgery do not significantly reduce
pain.

However, further research

IS

needed.

Additional studies are

needed to address both the dosage and volume of morphine
injections, psychological factors such as preoperative pain scores,
tourniquet release time, mode of anesthesia, and alternative opioids
such as bupivacaine.

Additional research should also be performed

following surgical procedures other than arthroscopy, as pain is a
prevalent problem.

For example, it has been reported that 75% of all

TKA's (total knee arthroplasties) have significant pain despite
supplemental analgesics 43 .
Comprehensive, double-blinded studies addressing these
variables and areas for research would solidify previous conflicting
results and add to the knowledge base.
physicians, clinicians, and patients alike.

22

This would be a benefit to
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H; ,n illi' ~ ned vet effective analgesic has become more apparent. llle greatest demand for analgesics comes during the first 2
:" " !I ,; \ " ,,;t, 'rl'ratively. Arthroscopy patients are often released from tlie hospital within 4-6 hours following surgery.

; " !;
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''''t'll

! '!I ' ,! .. .. "f "pioids to control postoperative pain is widespread with few side effects provided the patient is properly
,!;. i .' .. ! ' TITI t ivc period, Opioid drugs have been previously administered post0{leratively by intramuscular injection,
," ;
i!' n , :1111.1 epIdural catheters.
IIowever, some of these methods of admmistration do not lend themselves

attended li
intraveno
~
well to th
,, : k ' " '1'\' patient who is released from the hospital within a few hours of surgery. In addition, the traditional administrali('
,; ' T i ,i d :1 11 a I)!l'sics causes the drugs to work on the central nervous system which can increase the side effects of the mcdicatill

\ \ idl'lll'e has shown the presence of opioid receptors in peripheral joints.
If that evidence holds true, then peripher
,. in l;"i ' l r;Il i.,n of opioid drugs could be used which woula block the pain, but may not produce such undesirable central nerv(l!
. " " ," '-' \v\ ts as respiratory depression and sedation. These side effects are particularly unwanted in the patient who is to t
I "\.-;Ist'd from thc hospital within hours after surgery.
\ ,' " ' ( 1)1

~ :'"

: ' i" limited research which has found
.' 'I: I" ;, "I'Y pat knts. Unfortunately the full

the use of intraarticular morphine to be useful in controlling pain in post knt
details of these studies have not been published. Furthermore, the researchers h:l\
fl, ,! (. ; ;I, i '~hcd an effeclive dosage for the medication; and have arbitrarily used either a 050r 1.0 mg. dose of morphine sulfal
' I,., , "' , O!,li ~ hmcnt of a minimal effective dosage would be desirable to reduce the side effects.
i :,

\ " 11

I''''l' of this study is twofold: I) to determine if intraarticularly administered morphine reduces postoperative raill i
the evidence fro,

, .. " '!' ,lI i .11" tn a placeho, and 2) attemrt to determine a minimal effective dosage. Because we want to test
i ,( ,. 111 ' ';lll(lics, and estahlish a c1inica dosage of the medication, the use of human subjects is required.

('nil Inform-JtlCt"l pertinent to yrur req..aest to utilize tl...rTli!n subjects In ycur project or activity
~'nll d t>o Ire luded Ct"I th Is for1tl. \It)er4t apprq:>r I ate at tach sect lens fran ycur prOlXlSa I Inc Iud I rY1
rlata oolloct ICt"I InstnIre"1ts v.here applicable.
'-:.1
(Oescr lbe proced..tres to v.nlch tunans will be subjected.)
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to examine the dfeds of morpbine injected into the knee on postoperative pain in individuals undergoing knee

'1 " :r:diVl' ,pain will he decrcased with intraa~ticular morphi~e.
, I I , '( Is will hc ret!uc("d compared to narcotics used systemically,
\ '!,' Ti l i,' dpse will hc identified which provides optimum pain relief with few side effects.

\' , " I,
, ' 1, ; "
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' i 'n ldi " idu:ds hetween thc ages of 15-60 (malc and female), who are not allergic or sensitive to morphine and who have heen
Hle d to undergo knee arthroscopy to help treat their knee condition, will be invited to {>articipate. Refusal by thc pntient

' ,, ' , 'Ill :' !<"

: ' ,L,;I!. il':ll c in the study will in no way affect , the quality of orthopedic care they receive.
for their pnrticipation_

Participants will receive no

" ' \i ! q" ' ! h , tl i (l"
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will be performed at the United Hospital by Dr. Brian T. Briggs, Orthopedic Surgeon. Postoperative assessment s
the direction of Lori Klabunde, Nurse Practitioner. All patlents will be educated about the postoperative pain
I l1 l'nt ~ and the use of the Visual Analogue Scale prior to surgery (enclosed).

!I , " ,'!

, ili :,

(',,(,lanation of the study will be provided by Dr. Briggs prior to surgery, and the patient will be asked to read and sign
rm (cnclosed).

·1

"':ill he randomized into one of five groups as follows:
i'!Ha ;lrtieuiar injection of 10 cc's normal saline
j"'I<larticular in~ection of 10 cc's normal saline + 0.25
;"tr;wrtil.'ular in~edion of 10 cc's normal saline + 0,50
;'ll:aartil.'ular in~ection of 10 cc's normal saline + 0.75
III ! I :l:lIt icular injection of 10 cc's normal saline + 1.00
, I, 'nl'k-hlinued

mg.
mg.
mg.
mg.

morphine
morphine
morphine
morphine

system, once arthroscopy is completed, each patient will be injected with one of the above solutions, The

'o dl ht' asked to complete the Visual Analogue Scale at 1 hour postol'eratively, 2 hours postoperatively, 3 hours
," " " 'j" ,! .li '.l f:ly and 6 hours postoperatively, They.will also be sent home witli a scale to fill out approximatefyi4 hours after the
' t: i ' :,,' ; \ '
I bl'se scales are completed by simply 'placing a vertical line on a scale to mark the dewee of pain they're experiencin~
: "
i ' !l i: nt \\'ill he given supplemental analgeSia as it is required in the form of intramuscular mjections and/or oral agents. ;\11
" " I ' ; : \ " :!I~' I1I, al :ll1algesicswilrlle documenteoand used in the evaluation process.

p ,1 10 III

Schedule II narcotic medication commonly used to relieve pain. When administered intramuscularly, intravenously,
10-20 m~. every 4-6 hours. Given by the above mentioned roult's,
d . , rr' ,i ;'" ;ll't -; upon the central nervous systcm to produce pain rehef without loss of sensation or consciousness.
Morphine i~
., , ! , h ; 1" "('pt ed hy the .... );\ and has been used for many years.
'. 1.. , philH' j ,

:I

" . h- !,\, "'tlt, the standard recommended dose is between

, " . ';;:'1 '.ide dfects of morphine include respiratory depression, nausea and vomiting, itching, urinary retention, and a sense \If
: ,; , j " , ( : ! , ;\n allergic reaction to morphine may also occur in those not aware of a previous allergy.
: j , ;

!." ,!i:llion will be prepared in the United Hospital Pharmacy under the direction of Dr. Bill Reay, Pharmacy Director
\ i a Is will he randomized and sent to surgery prior to each arthroscopy.

:!" ' ' .1 : ' : '
,

"

dl he closely monitored by specially trained nurses postoperatively for side effects. Medications will be availahle to heir
, id l' dkcts ,

' i! ' '0 '

. ' :,1 " j
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(DescrIbe the benefIts to the Indlvlcllal or ~Iety.)

" , ' , ;, ' " . ,' : ll'lhJ'(1~r(lpic ~ arc rerformed on an outpatient basis, pain is present postoperatively which requires some f<'1'1ll " I
', ; IIl('rli,':rli"I1 , Morrhine is a very effective medication used to control pain. The side effects of morphine arc causcd b\
, "
:, ,, I hI' l'cnlrnl nervOlls system . By directly injecting morphine into the joint, the central nervous system is not affl'c\I'll
, ;' i '
I h,: ,ide effects arc reduced. Research has proven that there are special receptors present within the joint that wil
.,; : I I : ':t I1\ I1wdirat ion when injected and, therefore, relieve pain.
i

, '""Ii,.'s have also rroven that low dose morphine injected into the joint provides safe, effective pain relief devoid Ilf ,ilil
!.,'I';lIl<;e pnt ients ret urn home so quickly after surgery (often within 4-6 hours), it is imperative that adequate pain wnt rc I
, : ' : " 'f' II ,. I1t'd, and helrful if this can be done with few side effects.
: '

"i : ,
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(Oeser lbe the risks to the SJbJect and preccut lens that will be taken to minimize thEm The o:ncept
of risk g:)eS be)'a1d phYSical risk and InclUdes risks to the subject's dlgllty am self r
t
~I I as psycrolog lcaI • erotlc:nal or behaVioral risk. If data are (X)llected Ytfllch COlI~o:e as
h;mnful or robarrasslng to the 9JbJect If a~lated with him or her, then describe the rre~ to
be used to Insure the cx:nfldentlallty of data obtained, Including plans for final dlsposltl
destruct len, debr lef Ing proced..lres, etc.)
'
en or

! iii ;'n! " lIli " l side
,: , p: ".. ,'·i· '11. nausea
,

'f'

effects of morphine are well-documented when it is given by traditional routes. These include resrirator)
and vomiting, Itching, somnolence, and an allergic reaction.
'"

b I ,, "!: nt is closely monitored by specially trained professionals after surgery. Vital signs are measured every 15-30 minutl'~

':\- i ,', ,( !J patient is carefully assessed for any complications. Medications may be given to help control side effects.
\'; r ,d ; ' ,; \ fiks anLl hospital records will be kept confidential. Once completed, files containing study information will be kep i
,' , , ' , ·,di dt'lltiai filc hy Lori Klabunde at the Grand Forks Clinic.
,
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A c:cpy of the CXl£t:NT RnA to be slg"led by the &.Jbjeet (If applicable) and/or any statarcnt
to be read to the &.Jbject !tnlld ~ attached to this form. If ro aN59lT RR.4 Is to be u~ .
dxl..rrmt the procedJres to be used to aS9.lre that Infr Irgerrent upcn the subject's rights will

rot ocrur.
Des::r lbe v.nere slg"led cx::nsent forms will be kept and for \'tt1at period of tlrre.

,', 't

m .L IOC R£VIEW forward a sl~ or Iglnal and 12 cx::ples of this cx:rrpleted form and, v.nere applicable, 12
o f the prq:x:lSed cx:nsent form, QJeStlcrnalres, etc., and any support Ing cbctrrentatlcn to:

'; .''{ ? ~ '::5

r I (>~'1 ror Tve I t
1i)~ Sxl t h Cb ILJTb Ia Road
Cr am Forks. W
;" . ~

58201

rxFWT or EXPEDITED R£VIEW forward a slgred original and a cx::py of the ccnsent form, Q.lestlcrnalres,

"! t c . , <"lnd any ~t1ng d:::x:::t.Jmntatlc:n to the address aOOve.

:'., : (' 1 ! ": ! ~ 5 am proced.lres 01 Use of I-t.nan SJbJects In ~Ical Park Instltutlc:ns awly to all activities
' : ·... ·· hh;:J w:"'" of H..rran SJbjects perfOf'1reCl by perscrnel cxn:ltctlng such activities. N::> activities are to be
j 'l ;~ !;)!~v J

.

"

v;lttnlt prior review and awroval of' the

~Ical

Park Instltutlc:nal RevleN O:mnlttee.

DATE: ______________

-..... _ - - - - - - - - - - - - - - - PI' Inc lpa I Investigator

DATE: ______________
f'r:::> JlXt Director

DATE :____________
':: lucrnt Adviser (v.nere applicable)

-4-

INFORMATION AND CONSENT FORM
The Effect of Intra-articular Morphine on Post-arthroscopy Pain

You are being invited to participate in a study being conducted by Dr. Brian Briggs and
his staff regarding the use of morphine to control postoperative pain. One goal of this
study is to determine if an injection of morphine directly into the knee joint following
your arthroscopic surgery will affect the amount of postoperative pain you experience.
The other goal is to determine a proper dosage for the morphine injection. Only subjects
who were normal and healthy prior to their knee problem will be included in this study.
Prior to your surgery you will be given instructions on the pain testing procedures that
will be done after surgery. For the testing, you will be asked to rate your pain on a scale
which varies from a response of "no pain" to "unbearable pain". In addition an examiner
will ask you to bend your knee, and then that examiner will measure the distance you
moved your knee. These same measurements will be conducted at 1, 3 and 6 hours after
your surgery. In addition, you will be asked to fill out a short questionnaire after 24
hours at home. You will be instructed on how to fill out the questionnaire.
As a participant in this study you will be randomly assigned to one of five (5) treatment
groups. Four of those groups will be given different dosage levels of morphine, and the
other group will be given a placebo injection. It is not clear at the present time which of
the treatment programs would be better for you. For this reason, the treatment plan which
is offered to will be based upon a method of randomization. Randomization means selection of a treatment by chance. This is predetermined by the doctor's staff, and selection of
treatment for each patient is done in a sequential manner. This is equivalent to flipping a
coin to select one of two treatments.
The actual testing procedure will only take approximately 5 to 10 minutes of your time.
The testing procedure should not cause you any discomfort or inconvenience over and
above the standard post-operative procedures.
As with the administration of any medication, there are some risks involved with the administration of morphine. Although the dosages of the drug used are well within normal
clinical guidelines, the use of morphine does carry some risk. Because morphine is used
on a routine basis, we do not anticipate any problems. However, potential risks may include respiratory depression (i.e. difficulty breathing), allergic reaction, nausea, vomiting,
itching and drowsiness. While you are in the hospital following your surgery, you will be
under the direct care of the hospital physician and nursing staff to monitor your progress
and intervene should you experience any problems.
The benefits to you as a participant include enhanced control of post-operative pain without the standard repeated drug injections which can increase the side effects of the pain
medication. A more effective means of controlling pain will ultimately lead to decreased
post-operative pain, better joint movement and less weakness.

Any information that is obtained in connection with the study and that can be identified
with you will remain confidential and will be disclosed only with your permission. The
data collected will be identified by a number known only by the investigators. You will
not be assessed any additional cost as a study participant.
Your decision whether or not to participate in this study will not prejudice your future
relationship with your doctor or with the United Hospital staff. If you decide to participate, you are free to discontinue participation at any time without prejudice.
The investigators involved are available to answer any questions you have concerning
this program. In addition, you are encouraged to ask any questions concerning this program that you may have in the future. Questions may be asked by calling Lori Klabunde
at 780-6112. A copy of this consent is available to participants in this study.
In the event that this research activity results in a physical injury, and the project is being
conducted in a health care facility, medical treatment will be available, including first aid,
emergency treatment, and follow up care as needed. Payment for any such treatment
must be provided by you and your third party payor, if any.

"ALL OF MY QUESTIONS HAVE BEEN ANSWERED AND I AM ENCOURAGED
TO ASK ANY QUESTIONS THAT I MAY HAVE CONCERNING THIS STUDY IN
THE FUTURE."
I have read all of the above and willingly agree to participate in this study explained to
meby ___________________________

Patient's Signature

Date

Parent or Legal Guardian's
Signature

Date

Witness (not the investigator) Date
I have explained fully to the patient the above objective of this study, what is to be
expected, and the possible complications.

Counseling Physician's Signature Date
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